Seguir
Khaled Abouzid
Khaled Abouzid
professor of pharmaceutical chemistry
E-mail confirmado em pharma.asu.edu.eg - Página inicial
Título
Citado por
Citado por
Ano
Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand
AD Khanolkar, V Abadji, S Lin, WAG Hill, G Taha, K Abouzid, Z Meng, ...
Journal of medicinal chemistry 39 (22), 4515-4519, 1996
2071996
Substrate specificity and stereoselectivity of rat brain microsomal anandamide amidohydrolase
W Lang, C Qin, S Lin, AD Khanolkar, A Goutopoulos, P Fan, K Abouzid, ...
Journal of medicinal chemistry 42 (5), 896-902, 1999
1601999
Synthesis of certain substituted quinoxalines as antimicrobial agents (part II)
MM Badran, KAM Abouzid, MHM Hussein
Archives of pharmacal research 26, 107-113, 2003
1532003
Discovery of potent VEGFR-2 inhibitors based on furopyrimidine and thienopyrimidne scaffolds as cancer targeting agents
MA Aziz, RAT Serya, DS Lasheen, AK Abdel-Aziz, A Esmat, AM Mansour, ...
Scientific reports 6 (1), 24460, 2016
1412016
Design and Synthesis of New Tetrazolyl- and Carboxy-biphenylylmethyl-quinazolin-4-one Derivatives as Angiotensin II AT1 Receptor Antagonists
MAH Ismail, S Barker, DA Abou El Ella, KAM Abouzid, RA Toubar, ...
Journal of medicinal chemistry 49 (5), 1526-1535, 2006
1382006
Design, synthesis and in vitro antitumor activity of 4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase
K Abouzid, S Shouman
Bioorganic & Medicinal Chemistry 16 (16), 7543-7551, 2008
1342008
Chimeric HDAC inhibitors: Comprehensive review on the HDAC‐based strategies developed to combat cancer
HM Hesham, DS Lasheen, KAM Abouzid
Medicinal Research Reviews 38 (6), 2058-2109, 2018
1302018
Design, synthesis and biological evaluation of novel pyridine derivatives as anticancer agents and phosphodiesterase 3 inhibitors
AH Abadi, TM Ibrahim, KM Abouzid, J Lehmann, HN Tinsley, BD Gary, ...
Bioorganic & medicinal chemistry 17 (16), 5974-5982, 2009
1302009
Pyridazinone derivatives: Design, synthesis, and in vitro vasorelaxant activity
K Abouzid, MA Hakeem, O Khalil, Y Maklad
Bioorganic & medicinal chemistry 16 (1), 382-389, 2008
982008
Phosphatidylinositol 3 kinase (PI3K) inhibitors as new weapon to combat cancer
FM Elmenier, DS Lasheen, KAM Abouzid
European journal of medicinal chemistry 183, 111718, 2019
932019
Penicillin binding protein 2a: An overview and a medicinal chemistry perspective
MAW Shalaby, EME Dokla, RAT Serya, KAM Abouzid
European journal of medicinal chemistry 199, 112312, 2020
852020
Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis
ZSBHJ Xin Ge, Min-Hong Pan, Lin Wang, Wei Li, Chengfei Jiang, Jun He, Khaled ...
cell death and disease 9, 1128, 2018
832018
Novel anti-inflammatory agents based on pyridazinone scaffold; design, synthesis and in vivo activity
K Abouzid, SA Bekhit
Bioorganic & medicinal chemistry 16 (10), 5547-5556, 2008
802008
Design, synthesis and biological evaluation of type-II VEGFR-2 inhibitors based on quinoxaline scaffold
MI Shahin, DA Abou El Ella, NSM Ismail, KAM Abouzid
Bioorganic Chemistry 56, 16-26, 2014
742014
Eco-friendly synthesis of novel cyanopyridine derivatives and their anticancer and PIM-1 kinase inhibitory activities
KAM Abouzid, GH Al-Ansary, AM El-Naggar
European journal of medicinal chemistry 134, 357-365, 2017
712017
Quinoxaline‐based scaffolds targeting tyrosine kinases and their potential anticancer activity
AMS El Newahie, NSM Ismail, DA Abou El Ella, KAM Abouzid
Archiv der Pharmazie 349 (5), 309-326, 2016
672016
Thieno [2, 3-d] pyrimidine based derivatives as kinase inhibitors and anticancer agents
EZ Elrazaz, RAT Serya, NSM Ismail, DA Abou El Ella, KAM Abouzid
Future Journal of Pharmaceutical Sciences 1 (2), 33-41, 2015
642015
How to train your inhibitor: Design strategies to overcome resistance to Epidermal Growth Factor Receptor inhibitors
SN Milik, DS Lasheen, RAT Serya, KAM Abouzid
European Journal of Medicinal Chemistry 142, 131-151, 2017
552017
Development of benzimidazole-based derivatives as antimicrobial agents and their synergistic effect with colistin against gram-negative bacteria
EME Dokla, NS Abutaleb, SN Milik, D Li, K El-Baz, MAW Shalaby, ...
European Journal of Medicinal Chemistry 186, 111850, 2020
542020
Design and synthesis of new quinoxaline derivatives as anticancer agents and apoptotic inducers
AMS El Newahie, YM Nissan, NSM Ismail, DA Abou El Ella, SM Khojah, ...
Molecules 24 (6), 1175, 2019
512019
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20